What's new

Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 11, Status: Authorised

May 23, 2025 - 14:55
 0
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

European Medicines Agency's data protection notice for selection and recruitment

Next Article

European Union example instances - E2B(R3) testing files

Related Posts

Human medicines European public assessment report (EPAR): Rystiggo, Rozanolixizumab, Date of authorisation: 05/01/2024, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0

External guidance on the implementation of the European...

May 15, 2025  0